These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7902634)

  • 1. Expression of the c-erbB-2 gene product as detected in cytologic aspirates in breast cancer.
    Allan SM; Fernando IN; Sandle J; Trott PA
    Acta Cytol; 1993; 37(6):981-2. PubMed ID: 7902634
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines.
    Skinner A; Hurst HC
    Oncogene; 1993 Dec; 8(12):3393-401. PubMed ID: 8247542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human models for studying malignant progression in breast cancer.
    Taylor-Papadimitriou J; D'Souza B; Berdichevsky F; Shearer M; Martignone S; Alford D
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():77-83. PubMed ID: 7905314
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
    Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
    In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gene expression in drug-resistant human breast cancer cells.
    Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
    Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
    Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology].
    Czerwenka KF; Zeillinger R; Kury F; Manavi M; Speiser P; Peschke M; Steinhart U; Hosmann JW; Kubista E
    Gynakol Rundsch; 1991; 31 Suppl 2():378-9. PubMed ID: 1686430
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of human epidermal growth factor receptor 2 protein and gene in fine needle aspiration cytology specimens and tissue sections from invasive breast cancer: can cytology specimens take the place of tissue sections?
    Sumiyoshi K; Shibayama Y; Akashi S; Nohara T; Iwamoto M; Kobayashi T; Nishimura H; Yoshinaka R; Harada T; Tanigawa N
    Oncol Rep; 2006 Apr; 15(4):803-8. PubMed ID: 16525662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
    Kerns BJ; Jordan PA; Huper G; Marks JR; Iglehart JD; Layfied LJ
    Mod Pathol; 1993 Nov; 6(6):673-8. PubMed ID: 7905629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
    Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
    Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.
    Giai M; Roagna R; Ponzone R; De Bortoli M; Dati C; Sismondi P
    Anticancer Res; 1994; 14(3B):1441-50. PubMed ID: 7915096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer.
    LeJeune S; Leek R; Horak E; Plowman G; Greenall M; Harris AL
    Cancer Res; 1993 Aug; 53(15):3597-602. PubMed ID: 8101763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
    Slesak B; Harlozinska A; Porebska I; Bojarowski T; Lapinska J; Rzeszutko M; Wojnar A
    Anticancer Res; 1998; 18(4A):2727-32. PubMed ID: 9703936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer.
    Homaei-Shandiz F; Ghavam-Nassiri MR; Sharifi N; Homaei-Shandiz AH; Taghizadeh-Kermani A; Torshizi SA; Ghafarzadegan K
    Saudi Med J; 2006 Dec; 27(12):1810-4. PubMed ID: 17143354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic proteins and prognostic correlations in breast cancer.
    Molina R; Filelia X; Segui MA; Climent MA; Pérez-Picañol E; Alonso C; Jo J; Ojeda B; Tandon AK; Ballesta AM
    In Vivo; 1993; 7(6B):585-9. PubMed ID: 7910764
    [No Abstract]   [Full Text] [Related]  

  • 18. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analyses of in situ breast cancer.
    Stratton MR; Collins N; Lakhani S; Sloane J
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():123. PubMed ID: 7905313
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.
    Hicks DG; Short SM; Prescott NL; Tarr SM; Coleman KA; Yoder BJ; Crowe JP; Choueiri TK; Dawson AE; Budd GT; Tubbs RR; Casey G; Weil RJ
    Am J Surg Pathol; 2006 Sep; 30(9):1097-104. PubMed ID: 16931954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.